Seminar Detail

Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians
Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians


When:  Tuesday, March 20, 2018 at 8:00 AM - 4:00 PM

This event is no longer available for purchase.

Other ways to Register: Call (800) 844-8260  
Credit Card Required for online registration | Contact us to redeem Gift Certificates

Single Registration
2+ Group Rate: per person
*** All prices are shown in US Dollars ***
View brochure for CE details

Phone:  610-265-7500
View Map

Student Discounts
If you are a student, please click here for registration information.

Group Discounts
If 5+ staff members from your facility are attending this event, please call (800) 844-8260 to learn more about our special rates.

In-House Options
If you would like this educational event brought to your facility, please click here for in-house training options.

Course Description
Attend this seminar and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.

You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. You will leave this seminar better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.
If there is no CE tab, please refer to the course brochure for continuing education information.
Learner Objectives:

  1. Analyze the major classes of antibiotics and their pharmacokinetic characteristics.
  2. Apply current evidenced-based approaches to select appropriate treatment regimens for common infections encountered in clinical practice.
  3. Prescribe antimicrobials based on empiric dosing recommendations.
  4. Plan goals of therapy and parameters for monitoring therapeutic response to antimicrobials.
  5. Recommend specific antimicrobial therapeutic drug monitoring to maximize efficacy and minimize toxicities (e.g., vancomycin and aminoglycosides).
  6. Develop preventative strategies to limit antimicrobial resistance.
  7. Design patient and caregiver education on the proper use of antimicrobials.
Program Outline

  • Antimicrobials
    • Drug classes
    • Pharmacokinetic Properties
      • Concentration-dependent killing
      • Time-dependent killing
      • Post-antibiotic effect
    • Common interactions with other drugs
  • Antibacterial Allergies - Sulfa and Penicillin
    • Define true allergy
    • Sulfonamide antibiotics vs non-antibiotics
    • Penicillin - Cephalosporin cross-sensitivity
  • Bacteria
    • Differentiation
    • Normal flora
    • Common pathogens
  • Antibacterial Resistance - Contributing Factors
    • Trends
    • Mechanisms of resistance
    • Contributing factors
  • Methicillin-Resistant Staphylococcus Aureus - Community versus Hospital Acquired
    • Differentiating between CA- and HA-MRSA
    • Current clinical practice guidelines
    • Pharmacologic management
  • Enterobacteriaceae Resistance
    • Extended Spectrum Beta-Lactamase (ESBL)
      • What are ESBLs
      • Pharmacologic management
    • Carbapenem-Resistant Enterobacteriaceae (CRE)
      • What are CREs
      • Pharmacologic management
  • Urinary Tract Infections
    • Bacterial Etiology, Signs and Symptoms and Diagnosis
    • Cystitis and pyelonephritis
    • Complicated and uncomplicated
    • UTIs in pregnancy
    • Treatment (IDSA Guideline Treatment Algorithm)
      • Acute
      • Recurrent and relapse
  • Clostridium Difficile Infection
    • Risk factors
    • Pharmacology management
    • Fecal Transplantation
    • Probiotics literature review
  • Community–Acquired Pneumonia
    • Bacterial etiology
    • Diagnosis
    • Typical vs. atypical
    • Treatment (IDSA/ATS Guidelines) and monitoring
      • Outpatient vs. inpatient
      • Empiric treatment
  • Healthcare–Associated Pneumonia
    • Bacterial etiology
    • Treatment (IDSA/ATS Guidelines)
    • Treatment Controversy
  • Upper Respiratory Tract Infections
    • Sinusitis and pharyngitis
      • Etiology (Viral vs. Bacterial)
      • Treatment
    • Bronchitis and Pertussis
      • Etiology (Viral vs. Bacterial)
      • Treatment
  • Skin and Soft Tissue Infections
    • Cellulitis
    • Diabetic foot infections
    • Bacterial etiology
      • Signs & symptoms
      • Treatment (IDSA Guidelines)
    • Osteomyelitis
      • Acute vs. Chronic
      • Oral considerations
  • Strategies to Improve Patient Adherence
    • IMS Model (Information-Motivation-Strategy)
    • Major predictors of poor adherence to medication
  • Antibacterial Resistance – Prevention Strategies
    • Mechanisms for drug resistance
    • 12 steps to prevent antimicrobial resistance (CDC)
    • Antibiotic stewardship
  • Emerging and Reemerging Viral Infections
    • Animals as sources
    • Drivers and ecological factors
    • Modes of transmission
    • Pharmacology management
  • Influenza
    • Clinical features
    • Diagnosis
    • Pharmacology management
  • Immunizations (Adult)
    • Types of Vaccines
    • General recommendations
    • Contraindications & precautions


Dr. Jason Cota is an associate professor and the vice chair of the Pharmacy Practice Department at the University of the Incarnate Word Feik School of Pharmacy. He also has over 10 years of experience practicing as an infectious diseases clinical pharmacist at the San Antonio Military Medical Center, where he is a credentialed provider with prescriptive authority.

Dr. Cota received his Doctor of Pharmacy and a Master of Science in Advanced Pharmacy Practice with an emphasis in infectious diseases research from The University of Texas at Austin. In conjunction with his Master of Science degree program, he completed a two-year Specialty Practice Residency in Pharmacotherapy at The University of Texas Health Science Center at San Antonio with an emphasis in both infectious diseases and nephrology.

Dr. Cota is a member of the Society of Infectious Diseases Pharmacists and has given several presentations at national and international meetings. His research has focused on antimicrobial and antifungal drug dosing in patient populations that are subject to altered pharmacokinetics, including critically-ill burn patients and those receiving renal replacement therapy. He has published a number of articles and has co-authored several book chapters in the areas of infectious diseases and nephrology.

Speaker Disclosures:

Financial: Jason Cota is vice chair and associate professor at the University of the Incarnate Word Feik School of Pharmacy. He receives a speaking honorarium from Merck. Dr. Cota receives a speaking honorarium for PESI, Inc.

Non-financial: Jason Cota is a member of the Society of Infectious Diseases Pharmacists.
Credits listed below are for full attendance at the live event only. Certificates of Completion are distributed at the conclusion of the live seminar for those who register prior to the event date and attend the full day. A letter of attendance will be issued to participants who register at the event, arrive late, or leave early. For those who registered day of (walk-ins), and are in full attendance, a certificate of completion for full CE credit will be sent within 30 days following the event. For those in partial attendance (arrived late or left early), an adjusted certificate of completion reflecting partial credit will be issued within 30 days (if your board allows). Please see “live seminar schedule” for full attendance start and end times. NOTE: Boards do not allow credit for breaks or lunch.

If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, or questions on home study credit availability, please contact or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

PESI, Inc. offers continuing education programs and products under the brand names PESI, PESI Healthcare, PESI Rehab and Psychotherapy Networker.

American Nurses Credentialing Center Logo
PESI, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 6.3 contact hours. PARTIAL CONTACT HOURS WILL BE AWARDED FOR PARTIAL ATTENDANCE.

This program offers 380 instructional minutes of pharmacology content which is designed to qualify for 6.3 contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board.

PESI, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this Knowledge-based activity qualifies for 6.3 contact hours. ACPE Universal Program Number: 0289-0000-17-007-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. You are required to complete a program evaluation/post-test and bring your e-Profile ID to the seminar to receive CPE credit. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at in order to obtain your NABP e-Profile ID.

This program has been reviewed and is approved for a maximum of 6.25 hours of clinical Category I CME credit by the American Academy of Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Live Programs and for Commercial Support of Live Programs.

This activity qualifies for 380 minutes of instructional content as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Credit Card Required for online registration | Contact us to redeem Gift Certificates